CYP19A1 and polycystic ovary syndrome: The metabolic alterations of PCOS contribute to placental dysfunction in affected mothers, such that increased insulin secretion reduces placental aromatase activity, exposing female fetuses to elevated testosterone (Dumesic et al., 2020).